Liver Transplantation

Anti-Hepatitis B Core Antigen Status Should Dictate Donor to Recipient Decision

Published in Hepatitis Weekly, February 5th, 2001

- by Sonia Nichols, staff medical writer -- An analysis of liver transplants performed in a region where there is a high prevalence of anti-hepatitis B virus core antigen (anti-HBc) positivity suggests that anti-HBc⁺ livers should only be relegated to specific recipients.

Those recipients should either be anti-HBc⁺ or anti-hepatitis B surface antigen positive (anti-HBs⁺), according authors of the study, who performed their analysis at the University Hospital of La Fe in Valencia, Spain.

The geographical region where the evaluation took place has a high rate of anti-HBc⁺ in the population. Martin Prieto,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2001-02-05)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry